Literature DB >> 2410099

Keratin immunoreactivity in the benign and neoplastic human prostate.

M K Brawer, D M Peehl, T A Stamey, D G Bostwick.   

Abstract

Keratin immunoreactivity in the benign and neoplastic human prostate was examined immunohistochemically using two monoclonal antibodies with differing specificities. One of these antibodies stained only the basal cells of the normal and hyperplastic prostatic epithelium, with no reactivity in tumor cells of prostatic adenocarcinoma. The other monoclonal antibody recognized a keratin protein present in all normal and hyperplastic columnar (secretory) epithelial cells, as well as in all cancer cells regardless of degree of tumor differentiation. In addition, the second antibody stained acinar and ductal epithelial cells exhibiting premalignant changes. Our findings indicate that keratin immunoreactivity differs among the epithelial cell populations of the human prostate, probably reflecting expression of different keratin proteins. The distinctive patterns of staining obtained with these two antibodies may assist in distinguishing hyperplastic from neoplastic prostatic epithelium, as well as in the recognition of basal cell hyperplasia, transitional cell metaplasia, and premalignant changes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2410099

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  46 in total

1.  Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis.

Authors:  A M De Marzo; V L Marchi; J I Epstein; W G Nelson
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

2.  Proliferative lesions of prostate: a multivariate approach to differential diagnosis.

Authors:  Fernanda de Barros Correia Cavalcanti; Venâncio Avancini Ferreira Alves; Julio Pereira; Cristina T Kanamura; Alda Wakamatsu; Luís Balthazar Saldanha
Journal:  Pathol Oncol Res       Date:  2005-07-01       Impact factor: 3.201

3.  Usefulness of immunoperoxidase staining with high-molecular-weight cytokeratin in the differential diagnosis of small-acinar lesions of the prostate gland.

Authors:  F P O'Malley; D J Grignon; D T Shum
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

4.  Basal epithelial cells of human prostate gland are not myoepithelial cells. A comparative immunohistochemical and ultrastructural study with the human salivary gland.

Authors:  J R Srigley; I Dardick; R W Hartwick; L Klotz
Journal:  Am J Pathol       Date:  1990-04       Impact factor: 4.307

5.  Keratin expression: a measure of phenotypic modulation of human prostatic epithelial cells by growth inhibitory factors.

Authors:  D M Peehl; G K Leung; S T Wong
Journal:  Cell Tissue Res       Date:  1994-07       Impact factor: 5.249

6.  Differential expression of cytokeratin mRNA and protein in normal prostate, prostatic intraepithelial neoplasia, and invasive carcinoma.

Authors:  Y Yang; J Hao; X Liu; B Dalkin; R B Nagle
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

Review 7.  Intermediate filament expression in prostate cancer.

Authors:  R B Nagle
Journal:  Cancer Metastasis Rev       Date:  1996-12       Impact factor: 9.264

Review 8.  MicroRNAs in prostate cancer: From function to biomarker discovery.

Authors:  Ahmed A Moustafa; Hogyoung Kim; Rasha S Albeltagy; Ola H El-Habit; Asim B Abdel-Mageed
Journal:  Exp Biol Med (Maywood)       Date:  2018-06

Review 9.  Polo-like kinase 1, on the rise from cell cycle regulation to prostate cancer development.

Authors:  Jijing Luo; Xiaoqi Liu
Journal:  Protein Cell       Date:  2012-03-23       Impact factor: 14.870

10.  Keratin profiles in normal/hyperplastic prostates and prostate carcinoma.

Authors:  H Okada; A Tsubura; A Okamura; H Senzaki; Y Naka; Y Komatz; S Morii
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.